XML 36 R21.htm IDEA: XBRL DOCUMENT v3.24.1
Revenue
 12 Months Ended
Dec. 31, 2023
Revenue [Abstract]  
REVENUE

14. REVENUE

 

We primarily offer the First Defense® product line to dairy and beef producers to prevent scours in newborn calves. Generally, our products are promoted to veterinarians as well as dairy and beef producers by our sales team and then sold through distributors. Our primary market is North America. We do sell into select international regions and may expand this international reach in the future. There were no material changes between the allocation and timing of revenue recognition during the years ended December 31, 2023 or 2022. We do not have any contract assets for which we have satisfied the performance obligations, but do not yet have the right to bill for, or contract liabilities such as customer advances. All trade receivables on our balance sheet are from contracts with customers. We incur no material costs to obtain contracts.

 

The following table presents our product sales disaggregated by geographic area:

 

   During the Years Ended December 31, 
   2023   %   2022   % 
United States  $15,949,382    91%  $17,020,797    92%
Other   1,522,287    9%   1,547,165    8%
Total Product Sales  $17,471,669    100%  $18,567,962    100%

 

The following table presents our product sales disaggregated by major product category:

 

   During the Years Ended December 31, 
   2023   %   2022   % 
First Defense® product line  $17,293,933    99%  $18,411,949    99%
Other animal health   177,736    1%   156,013    1%
Total Product Sales  $17,471,669    100%  $18,567,962    100%